09/08/2026
Based on the emails from CMS, here are the statistics regarding various fraud, waste, and abuse (FWA) initiatives:
Medical Equipment (DMEPOS) Fraud
• $3.4 Billion Scheme: In September 2026, CMS identified 11 medical supply companies involved in $3.4 billion of suspected fraudulent billing.
• Preventive Action: CMS prevented $1.5 billion in suspected fraudulent DMEPOS billing in 2025.
• 2026 Suspensions: Over $226 million in suspect DME billing was suspended in 2026.
Laboratory Fraud
• Total Enforcement: Over $1.6 billion in potentially improper Medicare laboratory payments has been stopped.
• Breakdown of Actions:
o $732 million saved from the revocation of 157 fraudulent labs.
o Over $500 million in potentially fraudulent payments halted via 185 payment suspensions.
o $276 million recouped from 442 identified overpayments.
o $127 million prevented due to 85 law enforcement referrals.
Medicaid Fraud War Room (MFWR)
• Impact: Stopped more than $203.3 million in improper payments in its first 88 days (launched April 2026).
• Provider Oversight: Identified 50 unique high-risk providers.
• Enforcement Details:
o $160.7 million in Medicaid payments targeted via 42 federal notices of intent to exclude providers.
o $46.2 million in Medicaid payments addressed through 15 state enforcement actions.
Hospice and Home Health Agency (HHA) Enforcement
• LA Pilot: Suspended $70 million in payments to 773 hospices and 23 HHAs.
• National Impact: An additional $23 million in payments were suspended for suspect hospice providers nationally in 2026.
Minnesota Medicaid Funding Deferral
• Deferral Amount: In February 2026, CMS deferred $259.5 million in federal Medicaid funding to Minnesota due to program integrity concerns.
2025 Fiscal Year Overview
• Total Savings: CMS achieved $42 billion in savings.
• Payment Suspensions: $5.7 billion in suspected fraudulent Medicare payments were suspended.
• Provider Accountability: Billing privileges for 5,586 providers and suppliers were revoked.
• Law Enforcement: 372 fraud referrals were made, representing $3.7 billion in billing.
2026 Year-to-Date (Performance Metrics)
• Overpayments Identified: $1.8 billion identified via medical review.
• Recouped Funds: $378 million collected from post-payment reviews.
• Payment Suspensions: Over $539 million in suspected fraudulent Medicare payments suspended.
• Fraud Defense Operations Center: Accounted for over $371 million in suspended payments involving 267 providers since January 1, 2026.